Cost-effectiveness of NALIRIFOX versus Nab-paclitaxel and gemcitabine in previously untreated metastatic pancreatic ductal adenocarcinoma

Cost-effectiveness of NALIRIFOX versus Nab-paclitaxel and gemcitabine in previously untreated metastatic pancreatic ductal adenocarcinoma

Abstract Background & aims The NAPOLI 3 trial demonstrated that compared to the nab-paclitaxel and gemcitabine (GemNab) regimen, the NALIRIFOX (5-fluorouracil, leucovorin, liposomal irinotecan, oxaliplatin) regimen can significantly improve patients' overall survival (OS) and progression-fr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wenjie Liu, Yuting Fang, Chao Zhang, Midan Xiang, Lijuan Qi, Aijiang Su, Yongkun Sun
Format:	Article
Language:	English
Published:	BMC 2025-04-01
Series:	BMC Gastroenterology
Subjects:	Metastatic pancreatic ductal adenocarcinoma NALIRIFOX Nab-paclitaxel and gemcitabine Cost-effectiveness
Online Access:	https://doi.org/10.1186/s12876-025-03867-2
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nab-Paclitaxel plus gemcitabine in patients with metastatic pancreatic adenocarcinoma: experience of use
by: Elena Ferris Villanueva, et al.
Published: (2015-02-01)

ABCG2 protein expression in tumors of patients with non-resectable pancreatic cancer treated with gemcitabine and nab-paclitaxel
by: Susy Shim, et al.
Published: (2025-06-01)

Real-world evidence of chemotherapy effects in advanced pancreatic ductal adenocarcinoma: prognostic significance of TP53 status in gemcitabine plus nab-paclitaxel therapy
by: M. Sugimori, et al.
Published: (2025-09-01)

Pancreatic ductal adenocarcinoma in a patient with pancreas divisum and gastrointestinal duplication cyst: a case report
by: Naoto Takahashi, et al.
Published: (2021-08-01)

Physicochemical Stability of Nab-Paclitaxel (Pazenir) Infusion Dispersions in Original Glass Vials and EVA Infusion Bags
by: Helen Linxweiler, et al.
Published: (2024-10-01)

Camrelizumab, an Anti‐PD‐1 Monoclonal Antibody, Plus Carboplatin and Nab‐Paclitaxel as First‐Line Setting for Extensive‐Stage Small‐Cell Lung Cancer: A Phase 2 Trial and Biomarker Analysis
by: Jia Yu, et al.
Published: (2025-08-01)

The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer – the SERAPHINA study
by: Andreas Schneeweiss, et al.
Published: (2025-06-01)

An 81-Year-Old Geriatric Patient with Metastatic Pancreatic Cancer Demonstrating Excellent Response and Well Tolerance to NALIRIFOX: A Case Report and Literature Review
by: Bayan Khasawneh, et al.
Published: (2025-05-01)

Safety and efficacy of generic nab-paclitaxel-based therapy in Chinese patients with malignant tumors in a real-world setting: a multicenter prospective observational study
by: Fei He, et al.
Published: (2024-11-01)

Conversion surgery for an initially unresectable, locally advanced pancreatic cancer after induction chemotherapy and carbon-ion radiotherapy: a case report
by: Takeshi Fujishiro, et al.
Published: (2018-09-01)

A combination of paclitaxel and gemcitabine in an intensive dose-dense neoadjuvant chemotherapy schedule for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014-08-01)

TSPAN15 sustains ITGB1 stability to block gemcitabine-induced ferroptosis in pancreatic ductal adenocarcinoma through the FAK/AKT/Mtor-gpx4 cascade
by: Peng Nan, et al.
Published: (2025-09-01)

Intensified dose-dense neoadjuvant chemotherapy using paclitaxel-gemcitabine and docetaxel-doxorubicin combinations for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014-07-01)

ANP32E expression in pancreatic cancer is associated with impaired gemcitabine efficacy and poor patient prognosis
by: Xiaohong Liu, et al.
Published: (2025-08-01)

Radical resection of an initially unresectable intrahepatic cholangiocarcinoma after chemotherapy with using gemcitabine, cisplatin, and S-1: report of a case
by: Masashi Tsunematsu, et al.
Published: (2019-06-01)

The Effect of Kappa Phases on Tribocorrosion Behaviour of Nickel Aluminum Bronze (NAB) and Manganese Aluminum Bronze (MAB)
by: Carlos Berlanga-Labari, et al.
Published: (2025-06-01)

Nab-paclitaxel plus cisplatin versus gemcitabine plus cisplatin as first-line treatment in advanced biliary tract cancer: results of a multicentre, randomised, phase II trial
by: Xiao Yang, et al.
Published: (2025-08-01)

Costs of First-Line Treatment With FOLFIRINOX, Modified FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma
by: Syvart Dennen, et al.
Published: (2025-08-01)

Weekly paclitaxel in escalating doses in a patient with anthracycline-resistant, triple-negative, metastatic breast cancer with severe liver dysfunction
by: Ajay Gupta
Published: (2012-01-01)

Retrospective analysis of the effectiveness and tolerability of nab‐paclitaxel in Chinese elderly patients with advanced non‐small‐cell lung carcinoma
by: Shuhang Wang, et al.
Published: (2020-05-01)

Micellar paclitaxel in the treatment of patients with tumors of the female reproductive system
by: A. G. Kedrova, et al.
Published: (2019-11-01)

Improved Antitumor Efficiency of N4-Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy
by: Wang D, et al.
Published: (2024-12-01)

Gemcitabine: immunomodulatory or immunosuppressive role in the tumor microenvironment
by: Mahnaz Nemati, et al.
Published: (2025-04-01)

Gallbladder metastasis in invasive ductal breast cancer with concurrent gallstones and gallbladder carcinoma
by: Rujuan Wang, et al.
Published: (2025-07-01)

Bevacizumab, tislelizumab and nab-paclitaxel for previously untreated metastatic triple-negative breast cancer: a phase II trial
by: Wei Yang, et al.
Published: (2025-04-01)

Cost-effectiveness analysis of penpulimab plus carboplatin-paclitaxel as first-line treatment for metastatic squamous non-small-cell lung cancer in China
by: Luwei Wang, et al.
Published: (2025-07-01)

Enzyme-responsive vitamin D-based micelles for paclitaxel-controlled delivery and synergistic pancreatic cancer therapy
by: Diana Peixoto, et al.
Published: (2025-04-01)

PRMT5 Identified as a Viable Target for Combination Therapy in Preclinical Models of Pancreatic Cancer
by: Xiaolong Wei, et al.
Published: (2025-06-01)

Efficacy of albumin-bound paclitaxel versus paclitaxel in esophageal cancer: a systematic review and meta-analysis
by: Jiayang Song, et al.
Published: (2025-08-01)

PENURUNAN NILAI HANTARAN TULANG PADA PENDERITA KARSINOMA NASOFARING DENGAN KEMOTERAPI BERBASIS PLATINUM: KOMBINASI NEOADJUVANT PACLITAXEL-CISPLATIN DAN PACLITAXEL-CARBOPLATIN
by: Cika Apriliana, et al.
Published: (2019-02-01)

The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre‐clinical study
by: Kaan Low, et al.
Published: (2024-09-01)

FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma
by: Tung-Wei Hsu, et al.
Published: (2025-02-01)

Cost-effectiveness analysis of nimotuzumab combined with gemcitabine for K-Ras wild type locally advanced or metastatic pancreatic cancer in China
by: Rong Long, et al.
Published: (2025-02-01)

Mandibular metastasis of invasive ductal carcinoma of the breast: a case report
by: Faraz SeyedForootan, et al.
Published: (2025-08-01)

Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized comparative study
by: Sanjoy Roy, et al.
Published: (2011-01-01)

Solitary testicular metastasis post-prostatectomy for prostatic ductal adenocarcinoma: case report and literature review
by: Bo Chang, et al.
Published: (2025-02-01)

Synthesis and properties of magnetically sensitive nanocomposites based on magnetite and gemcitabine
by: A. L. Petranovska, et al.
Published: (2018-11-01)

First case report of neoadjuvant gemcitabine and S-1 for locally advanced unresectable duodenal adenocarcinoma
by: Jiro Kimura, et al.
Published: (2022-05-01)

Nanoparticle albumin-bound paclitaxel – first step of nanotechnology into clinical practice
by: R. N. Alyautdin, et al.
Published: (2022-06-01)

Successful treatment of pediatric post-liver transplant Kaposi`s sarcoma with paclitaxel
by: Hilal Susam Şen, et al.
Published: (2020-10-01)